Trials / Suspended
SuspendedNCT01268670
The Addition of Oral Analgesics to LET During Laceration Repair
Adjunctive Oral Analgesia for Laceration Repair: Assessing Pain in a Pediatric Emergency Department
- Status
- Suspended
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Children's Hospitals and Clinics of Minnesota · Academic / Other
- Sex
- All
- Age
- 4 Years – 10 Years
- Healthy volunteers
- Not accepted
Summary
Background Approximately 30 million children are treated in emergency departments each year in the United States, of which two to three million are children presenting with lacerations. Topical numbing medication is the standard of care in children with regard to pain control during laceration repair. While topical numbing medications are effective, children often require further pain control during laceration repair in the form of an injected numbing medication, which in itself is painful. No evidence currently exists regarding the concurrent use of oral pain medications to combat laceration procedural pain. Research Question Does the addition of ibuprofen or oxycodone to lidocaine, epinephrine, and tetracaine (LET) topical anesthetic provide more effective pain control than LET alone during laceration repair? Design This is a double-blinded, randomized-controlled study. Methods Subjects in all three groups will receive topical anesthetic. In addition to topical anesthetic, two groups of children will receive either of two oral analgesics, ibuprofen or oxycodone, while the third group will receive a placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ibuprofen | Subjects will receive topical LET and oral ibuprofen. |
| DRUG | Oxycodone | Subjects will receive topical LET and oral oxycodone. |
| OTHER | Placebo | Subjects will receive topical LET and oral placebo. |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2013-07-01
- First posted
- 2010-12-31
- Last updated
- 2013-07-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01268670. Inclusion in this directory is not an endorsement.